Copyright
©The Author(s) 2004.
World J Gastroenterol. Aug 15, 2004; 10(16): 2379-2382
Published online Aug 15, 2004. doi: 10.3748/wjg.v10.i16.2379
Published online Aug 15, 2004. doi: 10.3748/wjg.v10.i16.2379
Number of patients | |||
DA-9601 180 mg | DA-9601 360 mg | Cetraxate 600 mg | |
ITT analysis | 186 | 140 | 186 |
PP analysis | 171 | 120 | 166 |
- Citation: Seol SY, Kim MH, Ryu JS, Choi MG, Shin DW, Ahn BO. DA-9601 for erosive gastritis: Results of a double-blind placebo-controlled phase III clinical trial. World J Gastroenterol 2004; 10(16): 2379-2382
- URL: https://www.wjgnet.com/1007-9327/full/v10/i16/2379.htm
- DOI: https://dx.doi.org/10.3748/wjg.v10.i16.2379